Emergent BioSolutions Inc.
EBS
$5.08
$0.265.39%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 139.70M | 160.30M | 205.40M | 245.50M | 267.30M |
| Total Receivables | 190.00M | 121.60M | 84.20M | 149.50M | 79.80M |
| Inventory | 303.60M | 327.60M | 343.40M | 356.30M | 338.60M |
| Prepaid Expenses | 25.40M | 26.90M | 25.80M | 25.60M | 24.00M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 7.30M | 1.20M | 3.70M | 10.00M | 9.80M |
| Total Current Assets | 666.00M | 637.60M | 662.50M | 786.90M | 719.50M |
|
|
|||||
| Total Current Assets | 666.00M | 637.60M | 662.50M | 786.90M | 719.50M |
| Net Property, Plant & Equipment | 183.80M | 209.30M | 216.00M | 217.00M | 223.80M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 261.80M | 470.40M | 436.50M | 452.70M | 469.00M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.20M | 3.10M | 3.60M | 4.40M | 4.80M |
| Total Assets | 1.12B | 1.32B | 1.32B | 1.46B | 1.42B |
|
|
|||||
| Total Accounts Payable | 50.20M | 39.50M | 55.60M | 57.40M | 63.70M |
| Total Accrued Expenses | 43.30M | 31.40M | 54.00M | 50.50M | 45.10M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.50M | 2.40M | 2.40M | 1.80M | 1.80M |
| Total Finance Division Other Current Liabilities | 27.80M | 75.40M | 20.20M | 26.80M | 16.50M |
| Total Other Current Liabilities | 27.80M | 75.40M | 20.20M | 26.80M | 16.50M |
| Total Current Liabilities | 122.80M | 148.70M | 132.20M | 136.50M | 127.10M |
|
|
|||||
| Total Current Liabilities | 122.80M | 148.70M | 132.20M | 136.50M | 127.10M |
| Long-Term Debt | 581.80M | 573.60M | 572.10M | 663.10M | 667.80M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4.90M | 8.60M | 9.20M | 6.10M | 6.50M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 65.90M | 66.40M | 82.50M | 72.80M | 79.50M |
| Total Liabilities | 775.40M | 797.30M | 796.00M | 878.50M | 880.90M |
|
|
|||||
| Common Stock & APIC | 951.90M | 944.60M | 942.50M | 938.70M | 935.30M |
| Retained Earnings | -333.20M | -153.00M | -159.80M | -105.20M | -156.40M |
| Treasury Stock & Other | -277.30M | -268.50M | -260.10M | -251.00M | -242.70M |
| Total Common Equity | 341.40M | 523.10M | 522.60M | 582.50M | 536.20M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 341.40M | 523.10M | 522.60M | 582.50M | 536.20M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 341.40M | 523.10M | 522.60M | 582.50M | 536.20M |
|
|
|||||